Literature DB >> 9390950

On the mechanism of mucosal folding in normal and asthmatic airways.

B R Wiggs1, C A Hrousis, J M Drazen, R D Kamm.   

Abstract

Previous studies have demonstrated that the airway wall in asthma and chronic obstructive pulmonary disease is markedly thickened. It has also been observed that when the smooth muscle constricts the mucosa buckles, forming folds that penetrate into the airway lumen. This folding pattern may influence the amount of luminal obstruction associated with smooth muscle activation. A finite-element analysis of a two-layer composite model for an airway is used to investigate the factors that determine the mucosal folding pattern and how it is altered as a result of changes in the thickness or stiffness of the different layers that comprise the airway wall. Results demonstrate that the most critical physical characteristic is the thickness of the thin inner layer of the model. Thickening of this inner layer likely is represented by the enhanced subepithelial collagen deposition seen in asthma. Other findings show a high shear stress at or near the epithelial layer, which may explain the pronounced epithelial sloughing that occurs in asthma, and steep gradients in pressure that could cause significant shifts of liquid between wall compartments or between the wall and luminal or vascular spaces.

Entities:  

Mesh:

Year:  1997        PMID: 9390950     DOI: 10.1152/jappl.1997.83.6.1814

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  62 in total

Review 1.  Airway hyperresponsiveness in asthma: not just a matter of airway inflammation.

Authors:  V Brusasco; E Crimi; R Pellegrino
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

2.  Mechanical stress is communicated between different cell types to elicit matrix remodeling.

Authors:  M A Swartz; D J Tschumperlin; R D Kamm; J M Drazen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

Review 3.  Pharmacotherapy and airway remodelling in asthma?

Authors:  P A Beckett; P H Howarth
Journal:  Thorax       Date:  2003-02       Impact factor: 9.139

4.  Mechanotransduction through growth-factor shedding into the extracellular space.

Authors:  Daniel J Tschumperlin; Guohao Dai; Ivan V Maly; Tadashi Kikuchi; Lily H Laiho; Anna K McVittie; Kathleen J Haley; Craig M Lilly; Peter T C So; Douglas A Lauffenburger; Roger D Kamm; Jeffrey M Drazen
Journal:  Nature       Date:  2004-04-21       Impact factor: 49.962

5.  Local small airway epithelial injury induces global smooth muscle contraction and airway constriction.

Authors:  Jian Zhou; Martha B Alvarez-Elizondo; Elliot Botvinick; Steven C George
Journal:  J Appl Physiol (1985)       Date:  2011-11-23

6.  Induction of the plasminogen activator system by mechanical stimulation of human bronchial epithelial cells.

Authors:  Eric K Chu; Jason Cheng; John S Foley; Brigham H Mecham; Caroline A Owen; Kathleen J Haley; Thomas J Mariani; Isaac S Kohane; Daniel J Tschumperlin; Jeffrey M Drazen
Journal:  Am J Respir Cell Mol Biol       Date:  2006-06-22       Impact factor: 6.914

7.  TNF-α-converting enzyme/a disintegrin and metalloprotease-17 mediates mechanotransduction in murine tracheal epithelial cells.

Authors:  Tetsuya Shiomi; Daniel J Tschumperlin; Jin-Ah Park; Susan W Sunnarborg; Keisuke Horiuchi; Carl P Blobel; Jeffrey M Drazen
Journal:  Am J Respir Cell Mol Biol       Date:  2010-11-19       Impact factor: 6.914

Review 8.  Allergen-induced airway remodelling.

Authors:  C M Lloyd; D S Robinson
Journal:  Eur Respir J       Date:  2007-05       Impact factor: 16.671

9.  An EGFR autocrine loop encodes a slow-reacting but dominant mode of mechanotransduction in a polarized epithelium.

Authors:  Nikola Kojic; Euiheon Chung; Alvin T Kho; Jin-Ah Park; Austin Huang; Peter T C So; Daniel J Tschumperlin
Journal:  FASEB J       Date:  2010-01-07       Impact factor: 5.191

Review 10.  Biophysical basis for airway hyperresponsiveness.

Authors:  Steven S An; Jeffrey J Fredberg
Journal:  Can J Physiol Pharmacol       Date:  2007-07       Impact factor: 2.273

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.